Leptin and adiponectin: Their role in diabetes Aoife M. BrennanChristos S. Mantzoros Invited Commentary 16 April 2007 Pages: 1 - 2
Antioxidants and CVD in diabetes: Where do we stand now? Susie YimAtul MalhotraAristidis Veves OriginalPaper 16 April 2007 Pages: 8 - 13
Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome Glenn A. Gaesser OriginalPaper 16 April 2007 Pages: 14 - 19
The effects of diabetes mellitus on coronary artery bypass graft surgery Bruce J. Leavitt OriginalPaper 16 April 2007 Pages: 20 - 24
Adipokines and vascular disease in diabetes Barry J. GoldsteinRosario Scalia OriginalPaper 16 April 2007 Pages: 25 - 33
The renin-angiotensin system and insulin resistance Zhenqi Liu OriginalPaper 16 April 2007 Pages: 34 - 42
The role of glucose as an independent cardiovascular risk factor R. Jan-Willem MiddelbeekEdward S. Horton OriginalPaper 16 April 2007 Pages: 43 - 49
The DREAM trial: Using ramipril and rosiglitazone to prevent diabetes Viral ShahRichard E. Pratley Clinical trials report 16 April 2007 Pages: 53 - 55
Metabolic syndrome: Why the controversy? Richard E. Pratley OriginalPaper 16 April 2007 Pages: 56 - 59
The role of nutrition therapy and dietitians in the management of the metabolic syndrome Marion J. Franz OriginalPaper 16 April 2007 Pages: 60 - 65
Metabolic syndrome and cardiometabolic risk in PCOS Andrea J. CussonsBronwyn G. A. StuckeyGerald F. Watts OriginalPaper 16 April 2007 Pages: 66 - 73
The operative risk factors in the metabolic syndrome: Is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity? Fabrice M. A. C. MartensFrank L. J. Visseren OriginalPaper Open access 16 April 2007 Pages: 74 - 81